Developer docs
API playgroundTry for free, no card

Search company profiles

Digital Artefacts

Full company profile

uuid0007tff

Namestring
Digital Artefacts
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Digital Artefacts is a US-based custom technology services firm headquartered in Iowa City. Founded in 2000, the company specializes in developing web and mobile applications, Internet of Things (IoT) solutions, wearable electronics, and virtual/augmented reality (VR/AR) experiences. The company is structured as a private for-profit entity and operates with a headcount of 101-250 employees, with Joan Severson listed as co-founder and president.

Based on the available input data, the company's business model centers on custom development services across these emerging technology domains. No further details on revenue model, pricing mechanics, go-to-market motion, customer composition, or competitive positioning are disclosed in the source material. Twenty-four-plus years of continuous operation since 2000 indicates an established services firm in the custom development space, but the lack of disclosed operational, financial, or customer data makes a fuller characterization of the business infeasible from this input alone. The data is insufficient to assess product depth, technology stack, partnerships, geographic footprint, or revenue trajectory.

Short descriptiontext

Digital Artefacts is a US-based custom technology services firm founded in 2000 and headquartered in Iowa City, building web and mobile applications, IoT solutions, wearable electronics, and VR/AR experiences for clients across emerging technology domains.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersIowa City, United States
HQ citystring
Iowa City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
mobile app development, IoT development, wearable electronics, VR/AR development, web application development
NAICS code1 code
  • Computer and Peripheral Equipment Manufacturing33411
SIC code1 code
  • Computer Peripheral Equipment, Nec3577
Product category
Custom Technology Development Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial eSource Solutions
TypeSubscription Recurring
Description

Clinical Ink provides eSource platform solutions including Direct Data Capture, eCOA, eConsent, and related technologies to pharmaceutical sponsors and CROs for clinical trial data management. Revenue is generated through software licensing and services for clinical trials across various phases and therapeutic areas.

clinicalink.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Digital Artefacts is a custom technology development firm that designs and delivers web applications, mobile applications, Internet of Things (IoT) solutions, wearable electronics, and virtual reality/augmented reality (VR/AR) experiences for client projects. The firm operates as a multi-disciplinary development partner combining software and hardware expertise under one organization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Study build timeline reduced to 10 days
+2 more records
Product overview1 text field

Clinical Ink offers a unified eSource ecosystem platform designed for decentralized clinical trials. The platform integrates Direct Data Capture (DDC) technology and electronic Clinical Outcome Assessments (eCOA) for capturing clinical trial data. The core platform is supported by specialized modules including GlucoseReady™ (for diabetes/obesity trials with CGM integration), SPUR™ (adherence solution), Kaitality™ (weight management), eLAS® Suite (lupus trials), eConsent, Televisit, Sensors & Wearables, Digital Biomarkers, TrialLens™, and EDCXtra™. The ecosystem is designed to ingest data from multiple sources regardless of how it was captured, facilitating decentralized trials and shifting towards capturing data directly from patients.

Product and service5 records
1Web Application Development
CategoryWeb Development Services
Description

Design, engineering, and delivery of custom web applications for business clients.

2Mobile Application Development
CategoryMobile Development Services
Description

Design and development of custom mobile applications for business clients across iOS and Android platforms.

3IoT Development
CategoryIoT Development Services
Description

Design and development of Internet of Things (IoT) solutions, including connected devices and integrated systems for business clients.

4Wearable Electronics Development
CategoryHardware Development Services
Description

Design and engineering of wearable electronic devices and products for client projects.

5VR/AR Development
CategoryVR/AR Development Services
Description

Design and development of virtual reality (VR) and augmented reality (AR) experiences and applications for business clients.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-01
Description

Clinical Ink announced collaboration with Tandem Diabetes Care to integrate Automated Insulin Delivery data into the GlucoseReady connected device software platform, enabling seamless data flow for diabetes clinical trials.

Peers10 records
TypeBroad incumbent
Description

Medidata offers the Rave eCOA, EDC, and decentralized trial platform used by most large pharmaceutical sponsors. It is a broad incumbent with overlapping DDC, eCOA, and DCT capabilities, making it Clinical Ink's most significant scale competitor.

TypeBroad incumbent
Description

Veeva provides the Vault CDB and Vault EDC suite, including eCOA, CTMS, and study-startup tools for life sciences. It is a broad incumbent with deep enterprise relationships that overlap directly with Clinical Ink's sponsor and CRO target accounts.

TypeDirect peer
Description

Signant Health (formed from CRF Health and Bracket) provides eCOA, eConsent, patient engagement, and DCT solutions to pharma and CROs. It is a direct peer with a near-identical product set in eCOA, eConsent, sensors, and Televisit-style remote engagement.

TypeDirect peer
Description

Medrio offers EDC, eCOA, and DCT solutions for clinical trials with a focus on mid-market and academic sponsors. It is a direct peer competing for the same sponsor and CRO customers on EDC and eCOA build speed.

TypeBroad incumbent
Description

IQVIA operates the Oracle Clinical One platform spanning EDC, eCOA, RTSM, and DCT, in addition to CRO services. It is a broad incumbent competing on integrated platform breadth and deep pharma relationships.

TypeEmerging player
Description

Castor provides an EDC and ePRO platform for clinical trials, including DCT modules and patient-centric data capture. It is an emerging player with overlapping eCOA, eConsent, and remote data capture capabilities aimed at sponsors and CROs.

TypeEmerging player
Description

Y-Prime offers eCOA, IRT, and clinical supply solutions for clinical trials, with particular focus on eCOA build speed and patient-centric design. It is an emerging player with a directly comparable eCOA product and a similar mid-tier sponsor customer base.

TypeDirect peer
Description

Clario (formerly ERT) provides eCOA, cardiac safety, imaging, and digital biomarker solutions for clinical trials. It is a direct peer with strong overlap in eCOA, digital biomarkers, and DCT offerings to global pharma sponsors.

TypeEmerging player
Description

Curebase offers a DCT platform including eCOA, eConsent, telehealth, and remote patient engagement tools for sponsors and CROs. It is an emerging player with overlapping Televisit, eConsent, and eCOA functionality aimed at decentralized studies.

TypeEmerging player
Description

ObvioHealth is a DCT-focused CRO with an integrated eCOA, eConsent, Televisit, and sensor platform. It is an emerging player that competes for the same sponsor-led decentralized study budgets that Clinical Ink targets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Digital Artefacts

Custom Technology Development Servicesdigitalartefacts.com

Digital Artefacts is a US-based custom technology services firm founded in 2000 and headquartered in Iowa City, building web and mobile applications, IoT solutions, wearable electronics, and VR/AR experiences for clients across emerging technology domains.

What Digital Artefacts does

Digital Artefacts is a US-based custom technology services firm headquartered in Iowa City. Founded in 2000, the company specializes in developing web and mobile applications, Internet of Things (IoT) solutions, wearable electronics, and virtual/augmented reality (VR/AR) experiences. The company is structured as a private for-profit entity and operates with a headcount of 101-250 employees, with Joan Severson listed as co-founder and president.

Based on the available input data, the company's business model centers on custom development services across these emerging technology domains. No further details on revenue model, pricing mechanics, go-to-market motion, customer composition, or competitive positioning are disclosed in the source material. Twenty-four-plus years of continuous operation since 2000 indicates an established services firm in the custom development space, but the lack of disclosed operational, financial, or customer data makes a fuller characterization of the business infeasible from this input alone. The data is insufficient to assess product depth, technology stack, partnerships, geographic footprint, or revenue trajectory.

Digital Artefacts firmographics

Firmographics
Name
Digital Artefacts
Website
https://digitalartefacts.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
1–10 employees
Short description
Digital Artefacts is a US-based custom technology services firm founded in 2000 and headquartered in Iowa City, building web and mobile applications, IoT solutions, wearable electronics, and VR/AR experiences for clients across emerging technology domains.
Ownership category
akta.pro rank

Where Digital Artefacts is headquartered

Location

Headquarters

HQ city
Iowa City
HQ country
United States
HQ region
North America

Markets served

Digital Artefacts business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations

Revenue model

  1. Clinical Trial eSource Solutions: Clinical Ink provides eSource platform solutions including Direct Data Capture, eCOA, eConsent, and related technologies to pharmaceutical sponsors and CROs for clinical trial data management. Revenue is generated through software licensing and services for clinical trials across various phases and therapeutic areas.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Digital Artefacts product offering

Product offering

Core offering

Digital Artefacts is a custom technology development firm that designs and delivers web applications, mobile applications, Internet of Things (IoT) solutions, wearable electronics, and virtual reality/augmented reality (VR/AR) experiences for client projects. The firm operates as a multi-disciplinary development partner combining software and hardware expertise under one organization.

Product overview

Clinical Ink offers a unified eSource ecosystem platform designed for decentralized clinical trials. The platform integrates Direct Data Capture (DDC) technology and electronic Clinical Outcome Assessments (eCOA) for capturing clinical trial data. The core platform is supported by specialized modules including GlucoseReady™ (for diabetes/obesity trials with CGM integration), SPUR™ (adherence solution), Kaitality™ (weight management), eLAS® Suite (lupus trials), eConsent, Televisit, Sensors & Wearables, Digital Biomarkers, TrialLens™, and EDCXtra™. The ecosystem is designed to ingest data from multiple sources regardless of how it was captured, facilitating decentralized trials and shifting towards capturing data directly from patients.

Differentiator

Problem solved

Functional benefit

Products and services

  • Web Application Development Design, engineering, and delivery of custom web applications for business clients.
  • Mobile Application Development Design and development of custom mobile applications for business clients across iOS and Android platforms.
  • IoT Development Design and development of Internet of Things (IoT) solutions, including connected devices and integrated systems for business clients.
  • Wearable Electronics Development Design and engineering of wearable electronic devices and products for client projects.
  • VR/AR Development Design and development of virtual reality (VR) and augmented reality (AR) experiences and applications for business clients.

Quantifiable outcome

  • Study build timeline reduced to 10 days
  • +2 more outcomes

Companies that use Digital Artefacts

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Digital Artefacts technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature12 records

Digital Artefacts partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Tandem Diabetes CarecoreTechnology or Integration · 1 December 2025Clinical Ink announced collaboration with Tandem Diabetes Care to integrate Automated Insulin Delivery data into the GlucoseReady connected device software platform, enabling seamless data flow for diabetes clinical trials.

Scale indicators4 records

Digital Artefacts competitors and assessment

Company assessment

Broad incumbents

  • Medidata (Dassault Systèmes): Medidata offers the Rave eCOA, EDC, and decentralized trial platform used by most large pharmaceutical sponsors. It is a broad incumbent with overlapping DDC, eCOA, and DCT capabilities, making it Clinical Ink's most significant scale competitor.
  • Veeva Systems: Veeva provides the Vault CDB and Vault EDC suite, including eCOA, CTMS, and study-startup tools for life sciences. It is a broad incumbent with deep enterprise relationships that overlap directly with Clinical Ink's sponsor and CRO target accounts.
  • IQVIA (Oracle Clinical One): IQVIA operates the Oracle Clinical One platform spanning EDC, eCOA, RTSM, and DCT, in addition to CRO services. It is a broad incumbent competing on integrated platform breadth and deep pharma relationships.

Direct peers

  • Signant Health: Signant Health (formed from CRF Health and Bracket) provides eCOA, eConsent, patient engagement, and DCT solutions to pharma and CROs. It is a direct peer with a near-identical product set in eCOA, eConsent, sensors, and Televisit-style remote engagement.
  • Medrio: Medrio offers EDC, eCOA, and DCT solutions for clinical trials with a focus on mid-market and academic sponsors. It is a direct peer competing for the same sponsor and CRO customers on EDC and eCOA build speed.
  • ERT (now Clario): Clario (formerly ERT) provides eCOA, cardiac safety, imaging, and digital biomarker solutions for clinical trials. It is a direct peer with strong overlap in eCOA, digital biomarkers, and DCT offerings to global pharma sponsors.

Emerging players

  • Castor: Castor provides an EDC and ePRO platform for clinical trials, including DCT modules and patient-centric data capture. It is an emerging player with overlapping eCOA, eConsent, and remote data capture capabilities aimed at sponsors and CROs.
  • Y-Prime: Y-Prime offers eCOA, IRT, and clinical supply solutions for clinical trials, with particular focus on eCOA build speed and patient-centric design. It is an emerging player with a directly comparable eCOA product and a similar mid-tier sponsor customer base.
  • Curebase: Curebase offers a DCT platform including eCOA, eConsent, telehealth, and remote patient engagement tools for sponsors and CROs. It is an emerging player with overlapping Televisit, eConsent, and eCOA functionality aimed at decentralized studies.
  • ObvioHealth: ObvioHealth is a DCT-focused CRO with an integrated eCOA, eConsent, Televisit, and sensor platform. It is an emerging player that competes for the same sponsor-led decentralized study budgets that Clinical Ink targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat1 record

Key risks6 records

Key highlights6 records

Customer concentration

Digital Artefacts social profiles

Digital presence

Digital Artefacts compliance and trust

Trust signal

Compliance1 record

Digital Artefacts financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Digital Artefacts leadership team

Management profile

Number of profiles

Profiles1 record

Digital Artefacts funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Digital Artefacts M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Digital Artefacts

What does Digital Artefacts do?

Digital Artefacts is a custom technology development firm that designs and delivers web applications, mobile applications, Internet of Things (IoT) solutions, wearable electronics, and virtual reality/augmented reality (VR/AR) experiences for client projects. The firm operates as a multi-disciplinary development partner combining software and hardware expertise under one organization.

When was Digital Artefacts founded?

Digital Artefacts was founded in 1999. It employs 1 to 10 people.

Where is Digital Artefacts based?

Digital Artefacts is headquartered in Iowa City, United States, in the North America region.

How does Digital Artefacts make money?

One revenue line is on record: clinical Trial eSource Solutions.

Who are Digital Artefacts's main competitors?

Broad incumbents on record are Medidata (Dassault Systèmes), Veeva Systems and IQVIA (Oracle Clinical One). Direct peers are Signant Health, Medrio and ERT (now Clario). Emerging players are Castor, Y-Prime, Curebase and ObvioHealth.

Does Digital Artefacts have an API?

No public API is recorded for Digital Artefacts.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals